sermorelin and retatrutide together (Reta GLP-3) - 99%+ Purity Retatrutide vs. Tirzepatide: Dual vs.

(Rotar)

A summary of the key findings is available via Beckers Cardiology: Stopping GLP-1s linked to 22% rise in heart attack risk and CNBC: Stopping GLP-1s raises cardiovascular risks: Researchers described this phenomenon as metabolic whiplash : cardiovascular protection that builds over years can be substantially reversed in a fraction of that time

What you are actually choosing between in the lab If your research question is GLP-1 receptor pharmacology in isolation, semaglutide is the deepest-validated reference agonist

However, lips are thinner and more sensitive, so evidence is more anecdotal than lip-specific trials

Randomised withdrawal trials consistently show substantial regain after discontinuation

Why do patients stop GLP-1 drugs